- 专利标题: RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
-
申请号: US12203707申请日: 2008-09-03
-
公开(公告)号: US07683165B2公开(公告)日: 2010-03-23
- 发明人: James McSwiggen , Leonid Beigelman
- 申请人: James McSwiggen , Leonid Beigelman
- 申请人地址: US CA San Francisco
- 专利权人: Sirna Therapeutics, Inc.
- 当前专利权人: Sirna Therapeutics, Inc.
- 当前专利权人地址: US CA San Francisco
- 代理商 Elaine C. Stracker
- 主分类号: C07H21/02
- IPC分类号: C07H21/02 ; C07H21/04 ; A61K31/70 ; A01N43/04
摘要:
This invention relates to compounds, compositions, and methods useful for modulating interleukin and/or interleukin receptor gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of interleukin and/or interleukin receptor gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of interleukin and/or interleukin receptor genes.
公开/授权文献
信息查询